Switch theme
Sign up to access all valuation multiples
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
1982
19K+
LTM Revenue $2.4B
LTM EBITDA $250M
$3.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amedisys has a last 12-month revenue of $2.4B and a last 12-month EBITDA of $250M.
In the most recent fiscal year, Amedisys achieved revenue of $2.3B and an EBITDA of $177M.
Amedisys expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amedisys valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.3B | XXX | XXX | XXX |
| Gross Profit | $963M | $991M | XXX | XXX | XXX |
| Gross Margin | 43% | 42% | XXX | XXX | XXX |
| EBITDA | $129M | $177M | XXX | XXX | XXX |
| EBITDA Margin | 6% | 8% | XXX | XXX | XXX |
| Net Profit | $119M | -$9.7M | XXX | XXX | XXX |
| Net Margin | 5% | 0% | XXX | XXX | XXX |
| Net Debt | $394M | $272M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Amedisys's stock price is $91.
Amedisys has current market cap of $3.0B, and EV of $3.2B.
See Amedisys trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.2B | $3.0B | XXX | XXX | XXX | XXX | $4.44 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Amedisys has market cap of $3.0B and EV of $3.2B.
Amedisys's trades at 1.3x LTM EV/Revenue multiple, and 12.6x LTM EBITDA.
Analysts estimate Amedisys's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Amedisys and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.2B | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 17.8x | XXX | XXX | XXX |
| P/E | 69.4x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 14.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAmedisys's NTM/LTM revenue growth is 5%
Amedisys's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $43K for the same period.
Over next 12 months, Amedisys's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Amedisys's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Amedisys and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 38% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 12% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $43K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 34% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 34% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Aveanna Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amedisys acquired XXX companies to date.
Last acquisition by Amedisys was XXXXXXXX, XXXXX XXXXX XXXXXX . Amedisys acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Amedisys founded? | Amedisys was founded in 1982. |
| Where is Amedisys headquartered? | Amedisys is headquartered in United States of America. |
| How many employees does Amedisys have? | As of today, Amedisys has 19K+ employees. |
| Who is the CEO of Amedisys? | Amedisys's CEO is Mr. Richard M. Ashworth. |
| Is Amedisys publicy listed? | Yes, Amedisys is a public company listed on NAS. |
| What is the stock symbol of Amedisys? | Amedisys trades under AMED ticker. |
| When did Amedisys go public? | Amedisys went public in 1994. |
| Who are competitors of Amedisys? | Similar companies to Amedisys include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Amedisys? | Amedisys's current market cap is $3.0B |
| What is the current revenue of Amedisys? | Amedisys's last 12-month revenue is $2.4B. |
| What is the current EBITDA of Amedisys? | Amedisys's last 12-month EBITDA is $250M. |
| What is the current EV/Revenue multiple of Amedisys? | Current revenue multiple of Amedisys is 1.3x. |
| What is the current EV/EBITDA multiple of Amedisys? | Current EBITDA multiple of Amedisys is 12.6x. |
| What is the current revenue growth of Amedisys? | Amedisys revenue growth between 2023 and 2024 was 5%. |
| Is Amedisys profitable? | Yes, Amedisys is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
